'Usually everybody loves money': Trump's FDA chief to start giving bonuses for faster drug reviews

'Usually everybody loves money': Trump's FDA chief to start giving bonuses for faster drug reviews

The U.S. Food and Drug Administration is adopting a strategy long used in the private sector to increase productivity: paying employees to move faster. FDA Commissioner Marty Makary announced last week that the federal agency will begin offering performance-based cash bonuses to staff who complete drug reviews ahead of schedule. The pilot program, dubbed the “Reviewer Recognition and Excellence” program, involved “some wrangling” by the commissi…

New FDA bonuses for faster reviews meant to help address ‘critical workforce challenges’

A new bonus pilot program meant to reward fast-working FDA reviewers will be funded in part by money from industry user fees, the first details on how Commissioner Marty Makary plans to finance the incentive ...